FDA encourages genetics-aided warfarin dosing.
作者信息
Thompson Cheryl A
出版信息
Am J Health Syst Pharm. 2007 Oct 1;64(19):1994-6. doi: 10.2146/news070085.
PMID:17893404
Abstract
摘要
相似文献
1
FDA encourages genetics-aided warfarin dosing.
Am J Health Syst Pharm. 2007 Oct 1;64(19):1994-6. doi: 10.2146/news070085.
2
Pharmacogenomic testing for warfarin dosing: we are ready now.
Expert Rev Cardiovasc Ther. 2009 Dec;7(12):1483-5. doi: 10.1586/erc.09.117.
3
Genetic testing for warfarin dosing? Not yet ready for prime time.
Pharmacotherapy. 2008 Feb;28(2):141-3. doi: 10.1592/phco.28.2.141.
4
Pharmacogenetic-based dosing of warfarin.
Med Lett Drugs Ther. 2008 May 19;50(1286):39-40.
5
Warfarin and pharmacogenomic testing: what would Pascal do?
Pharmacotherapy. 2009 Mar;29(3):245-7. doi: 10.1592/phco.29.3.245.
6
Refining the use of warfarin through genetic testing.
Int Angiol. 2008 Aug;27(4):271-3.
7
Should we be applying warfarin pharmacogenetics to clinical practice? No, not now.
Ann Intern Med. 2009 Aug 18;151(4):270-3, W95. doi: 10.7326/0003-4819-151-4-200908180-00009.
8
Warfarin pharmacogenetics: ready for clinical utility?
Clin Lab Sci. 2009 Summer;22(3):151-5.
9
Pathology consultation on warfarin pharmacogenetic testing.
Am J Clin Pathol. 2011 Jan;135(1):13-9. doi: 10.1309/AJCPAO82OTNPUBLW.
10
Warfarin monitoring woes: a glimmer of hope with pharmacogenomics.
J Am Med Dir Assoc. 2008 Mar;9(3):199-200. doi: 10.1016/j.jamda.2007.12.007.
引用本文的文献
1
Personalised Medicine: The Odyssey from Hope to Practice.
J Pers Med. 2018 Sep 21;8(4):31. doi: 10.3390/jpm8040031.
2
Novel variants of major drug-metabolising enzyme genes in diverse African populations and their predicted functional effects.
Hum Genomics. 2009 Jan;3(2):169-90. doi: 10.1186/1479-7364-3-2-169.
Zotero 插件